LAZANDA - 51772-314-04 - (Fentanyl Citrate)

Alphabetical Index


Drug Information of LAZANDA

Product NDC: 51772-314
Proprietary Name: LAZANDA
Non Proprietary Name: Fentanyl Citrate
Active Ingredient(s): 400    ug/1 & nbsp;   Fentanyl Citrate
Administration Route(s): NASAL
Dosage Form(s): SPRAY
Coding System: National Drug Codes(NDC)

Labeler Information of LAZANDA

Product NDC: 51772-314
Labeler Name: Archimedes Pharma US Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022569
Marketing Category: NDA
Start Marketing Date: 20111017

Package Information of LAZANDA

Package NDC: 51772-314-04
Package Description: 4 BOTTLE, SPRAY in 1 CARTON (51772-314-04) > 8 SPRAY in 1 BOTTLE, SPRAY

NDC Information of LAZANDA

NDC Code 51772-314-04
Proprietary Name LAZANDA
Package Description 4 BOTTLE, SPRAY in 1 CARTON (51772-314-04) > 8 SPRAY in 1 BOTTLE, SPRAY
Product NDC 51772-314
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Fentanyl Citrate
Dosage Form Name SPRAY
Route Name NASAL
Start Marketing Date 20111017
Marketing Category Name NDA
Labeler Name Archimedes Pharma US Inc.
Substance Name FENTANYL CITRATE
Strength Number 400
Strength Unit ug/1
Pharmaceutical Classes Full Opioid Agonists [MoA],Opioid Agonist [EPC]

Complete Information of LAZANDA


General Information